Lymphocyte T-Cell
Immunomodulator (LTCI)
is the first and only
approved treatment aid*
in the United States for
Feline Leukemia Virus
(FeLV) and Feline
Immunodeficiency Virus
(FIV) infections.
IMULAN is focused
on providing innovative
solutions for complex
animal diseases.
Our policy is to provide
veterinarians access to
conditionally approved
products for diseases,
such as FeLV and FIV,
where no current
approved therapy
is available.
*Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy
and potency studies are in progress. LTCI is manufactured by T-Cyte Therapeutics, Inc. and is exclusively distributed by IMULAN and ProLabs.
